Building a Deep Understanding of the Bispecific Landscape
Situation
An early-stage client seeking funding to develop a new bispecific antibody needed robust and compelling competitive readiness talking points to share with investors.
Task
Articulate the bispecific landscape, highlight frontrunners with attributes resembling the client’s asset and explain how the client can win the competitive advantage.
Action
Identified all bispecific antibodies in development and sorted these by key attributes such as specificity, valence, platform technology, stage of development and response rates relative to monoclonal antibody counterparts.
Cross-referenced clinical trial databases, literature reviews, SEC filings, conference proceedings, patents, primary intelligence and company presentations to build concise narrative with a clearly-articulated storyline.
Leveraged our broad immuno-oncology expertise to develop a customized framework that enabled us to narrow a list of over 100 agents in development to a few key competitors, and established the client’s key differentiators relative to these competitors.
Results
The client was able to define and communicate their competitive advantage in a crowded landscape and leveraged this narrative to attract investors and top industry talent.
Distilled a large data set
Developed a concise narrative
Drew top industry talent
Defining the Competitive
Advantage Attracts Investors and Talent
No items found.
Please note: images are for illustrative purposes only.
By clicking "Accept cookies", you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our privacy policy.
By clicking 'Accept all cookies', you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our privacy policy.
